Rodrigo Pérez-Esparza (Rodrigo Perez-Esparza, R Pérez-Esparza)

Years Active: 2018-2020
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Rodrigo Pérez-Esparza, L F Kobayashi-Romero, A M García-Mendoza, R M Lamas-Aguilar, A Fonseca-Perezamador
Promises and concerns regarding the use of ketamine and esketamine in the treatment of depression. Acta psychiatrica Scandinavica 140 (2) (2020)
Oscar Rodríguez-Mayoral, Rodrigo Pérez-Esparza, Georgina Domínguez-Ocadio, Silvia Allende-Pérez
Ketamine as augmentation for the treatment of major depression and suicidal risk in advanced cancer: Case report. Palliative & supportive care 18 (1) (2020)
Mariana Espinola-Nadurille, Jose Flores-Rivera, Veronica Rivas-Alonso, Steven Vargas-Cañas, Gregory L Fricchione, Leo Bayliss, Iris E Martinez-Juarez, Laura E Hernandez-Vanegas, Ruben Martinez-Hernandez, Paola Bautista-Gomez, Rodolfo Solis-Vivanco, Rodrigo Pérez-Esparza, Paula A Bustamante-Gomez, Miguel Restrepo-Martinez, Jesús Ramírez-Bermúdez
Catatonia in patients with anti-NMDA receptor encephalitis. Psychiatry and clinical neurosciences 73 (9) (2019)
Rodrigo Pérez-Esparza, Teresa Corona, Ramiro Gilberto Ruiz-García, Nelcy Oñate-Cadena, Camilo de la Fuente-Sandoval, Jesús Ramírez-Bermúdez
Time until relapse after augmentation with single-dose ketamine in treatment-resistant depression. Psychiatry and clinical neurosciences 72 (8) (2018)

Rodrigo Pérez-Esparza.css-eqlu8i{font-size:small;padding-left:4px;} (Rodrigo Perez-Esparza, R Pérez-Esparza)